The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Related News Articles

Chairperson's File
Public
This is an incredibly dynamic and transformative time for health care. One resource I have found incredibly helpful in speaking with many of you and engaging…
Headline
Hospitals and health systems are urged to nominate candidates as soon as possible for the AHA Next Generation Leaders Fellowship so they can apply by the March…
Headline
In this conversation, Mindy Estes, M.D., former CEO of Saint Luke's Health System and former AHA board chair, and Tori Bayless, CEO of Luminis Health and AHA…
Headline
The AHA today announced the team from Columbia Memorial Hospital, a critical access hospital in Astoria, Ore., is the 2024 recipient of the Rural Hospital…
Headline
Longtime health care executive and former AHA Chair David Reed died last month at age 91.  Reed's career began at Cincinnati General Hospital, where he…
Headline
Ian Morrison, a highly regarded author, consultant and futurist, died last week. He specialized in long-term forecasting and planning with a particular…